Clinical Trials · NCT02907918
Neoadjuvant Study of Palbociclib in Combination With Letrozole and Trastuzumab in Stage II-III ER+ HER2+ Breast Cancer
- Phase
- Phase 2
- Recruitment status
- Terminated
- Sponsor
- Washington University School of Medicine
- Enrollment
- 26
- Start date
- Jun 2017
- Locations
- 3 sites, United States
- Primary endpoint
- Number of Participants With Pathologic Complete Response (pCR)